OpenAI says it’s training a new AI model called GPT-4b micro with Retro Biosciences, a longevity science startup that’s trying to extend human life by 10 years, according to MIT Technology Review. Retro, which is backed by Sam Altman, has been working with OpenAI for about a year on this research, according to the report. The GPT-4b micro model is trying to recreate a protein – a specific set called Yamanaka factor – that can transform human skin cells into youthful-looking stem cells. Retro believes that this protein is a great step towards building human organs and providing a supply of replacement cells. The model is slightly different from Google’s Nobel prize-winning AlphaFold, which predicts the shape of proteins, but it appears to be OpenAI’s first model created specifically for biological research. OpenAI and Retro told the MIT Technology Review that they plan to release their research on the model and its results.
OpenAI is trying to extend the lifespan of humans, with the help of longevity startups
